Bone marrow transplantation
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma.
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, Asad A Haider, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Portia Smallbone, Paul Lin, Jeremy Ramdial, Yago Nieto, Ali H Mohamedi, Umer R Siddiqui, Abdullah Jamil
Published: 202510.1038/s41409-025-02771-3
Abstract
Autologous hematopoietic cell transplantation (autoHCT) remains a therapeutic option for multiple myeloma (MM) at relapse. We retrospectively analyzed 650 patients who underwent delayed (n = 335) or salvage (n = 315) autoHCT at a single center from 2…
Preview only. Read the full abstract at the source